Ampicillin dosing in premature infants for early-onset sepsis: exposure-driven efficacy, safety, and stewardship

Objective Define optimal ampicillin dosing for empiric early-onset sepsis (EOS) therapy in preterm neonates. Study design We simulated ampicillin concentrations in newborns (birthweight 90% maintained concentrations >MIC beyond 48 h. With the 2-dose regimen, newborns maintained the mean concentra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of perinatology 2022-07, Vol.42 (7), p.959-964
Hauptverfasser: Le, Jennifer, Greenberg, Rachel G., Yoo, YoungJun, Clark, Reese H., Benjamin, Daniel K., Zimmerman, Kanecia O., Cohen-Wolkowiez, Michael, Wade, Kelly C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective Define optimal ampicillin dosing for empiric early-onset sepsis (EOS) therapy in preterm neonates. Study design We simulated ampicillin concentrations in newborns (birthweight 90% maintained concentrations >MIC beyond 48 h. With the 2-dose regimen, newborns maintained the mean concentration >MIC within the 48 h culture window and below neurotoxicity level. Infants 22–24 weeks’ gestation had higher drug concentrations and more prolonged exposure duration than 25–27 weeks’ gestation. Conclusions For EOS in preterm infants, two ampicillin doses (50 mg/kg) provided optimal bactericidal exposures, while minimizing potential toxicity.
ISSN:0743-8346
1476-5543
1476-5543
DOI:10.1038/s41372-022-01344-2